๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
TTX-080-001 is a Phase 1, open label, dose escalation and dose expansion cl...
Status
Recruiting
Location
Arizona Oncology Associates
Start Date
2020-07-14
Trial ID
NCT04485013
The aims of this study is to asses the predictive value of serum anti\_endo...
Status
Unknown
Location
Mohammed Zain Al_a'bdeen
Start Date
2020-12-01
Trial ID
NCT05851352
Treatments Being Tested
The purpose of this study is to determine whether nivolumab plus ipilimumab...
Status
Unknown
Location
Multiple Locations
Start Date
2017-12
Trial ID
NCT02982486
Treatments Being Tested
Monoclonal antibodies such as trastuzumab can locate tumor cells and either...
Status
Completed
Location
Gynecologic Oncology Group
Start Date
2000-09-18
Trial ID
NCT00006089
Treatments Being Tested
This research is designed to determine if experimental treatment with Antib...
Status
Recruiting
Location
Research Site
Start Date
2023-06-05
Trial ID
NCT05797168
Treatments Being Tested
This phase II trial is studying how well bevacizumab works in treating pati...
Status
Completed
Location
Gynecologic Oncology Group
Start Date
2006-03
Trial ID
NCT00301964
Treatments Being Tested
This randomized phase II trial studies paclitaxel, carboplatin, and bevaciz...
Status
Active Not Recruiting
Location
Saint Joseph's Hospital and Medical Center
Start Date
2009-09-14
Trial ID
NCT00977574
Treatments Being Tested
This phase II trial is studying the side effects of giving bevacizumab toge...
Status
Completed
Location
Hartford Hospital
Start Date
2008-09
Trial ID
NCT00723255
Treatments Being Tested
This phase II trial studies the effects of the combination of olaparib and ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2018-09-27
Trial ID
NCT03660826
This clinical trial is designed to evaluate the safety, pharmacokinetics, p...
Status
Recruiting
Location
The Kinghorn Cancer Centre
Start Date
2025-11-25
Trial ID
NCT07334119
Treatments Being Tested